Metropolitan Life Insurance Co NY Grows Stake in Xylem Inc (NYSE:XYL)

Share on StockTwits

Metropolitan Life Insurance Co NY raised its stake in Xylem Inc (NYSE:XYL) by 12.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,604 shares of the industrial products company’s stock after purchasing an additional 3,997 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in Xylem were worth $2,835,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Parnassus Investments CA raised its position in Xylem by 2.0% in the third quarter. Parnassus Investments CA now owns 6,533,437 shares of the industrial products company’s stock valued at $520,192,000 after purchasing an additional 126,027 shares during the period. Pictet Asset Management Ltd. grew its stake in Xylem by 6.8% in the third quarter. Pictet Asset Management Ltd. now owns 4,450,428 shares of the industrial products company’s stock worth $354,343,000 after purchasing an additional 282,822 shares in the last quarter. Invesco Ltd. grew its stake in Xylem by 0.6% in the second quarter. Invesco Ltd. now owns 2,052,305 shares of the industrial products company’s stock worth $171,654,000 after purchasing an additional 11,266 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its stake in Xylem by 12.1% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 1,966,002 shares of the industrial products company’s stock worth $486,505,000 after purchasing an additional 211,944 shares in the last quarter. Finally, Wells Fargo & Company MN grew its stake in Xylem by 21.0% in the second quarter. Wells Fargo & Company MN now owns 1,157,711 shares of the industrial products company’s stock worth $96,831,000 after purchasing an additional 201,248 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors.

XYL opened at $77.51 on Monday. The business’s 50 day moving average is $78.68 and its 200-day moving average is $78.43. The stock has a market cap of $13.98 billion, a PE ratio of 26.91, a price-to-earnings-growth ratio of 1.56 and a beta of 1.18. The company has a current ratio of 1.55, a quick ratio of 1.15 and a debt-to-equity ratio of 0.70. Xylem Inc has a twelve month low of $60.65 and a twelve month high of $85.67.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, October 31st. The industrial products company reported $0.82 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.82. Xylem had a return on equity of 19.14% and a net margin of 9.65%. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the company earned $0.77 earnings per share. The firm’s quarterly revenue was up .7% compared to the same quarter last year. As a group, analysts forecast that Xylem Inc will post 3.02 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 5th. Investors of record on Thursday, October 31st will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Wednesday, October 30th. This represents a $0.96 annualized dividend and a yield of 1.24%. Xylem’s payout ratio is 33.33%.

A number of equities analysts have issued reports on XYL shares. Cfra cut shares of Xylem from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Jefferies Financial Group started coverage on shares of Xylem in a report on Friday, September 20th. They issued a “buy” rating and a $90.00 target price on the stock. Zacks Investment Research cut shares of Xylem from a “hold” rating to a “sell” rating and set a $82.00 target price on the stock. in a report on Monday, October 14th. Royal Bank of Canada set a $79.00 target price on shares of Xylem and gave the stock a “buy” rating in a report on Friday, November 1st. Finally, Seaport Global Securities cut shares of Xylem from a “buy” rating to a “neutral” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $82.33.

In related news, SVP Colin R. Sabol sold 4,099 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $78.37, for a total transaction of $321,238.63. Following the sale, the senior vice president now owns 33,518 shares of the company’s stock, valued at $2,626,805.66. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Kenneth Napolitano sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $77.49, for a total value of $387,450.00. Following the sale, the senior vice president now directly owns 46,228 shares in the company, valued at approximately $3,582,207.72. The disclosure for this sale can be found here. In the last three months, insiders have sold 16,959 shares of company stock worth $1,313,986. 0.85% of the stock is owned by corporate insiders.

Xylem Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Read More: Correction

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.